Jason Crawford will present at AACR in San Diego on Monday, April 8. Title: Cryo-EM-guided enhancement of target selectivity of a novel p97 inhibitor for treating multiple myeloma and acute myeloid leukemia (Abstract 3883). Learn more at ow.ly/kEPG50R73uh #AACR24

Gandeeva Therapeutics will present at the 2024 @bloomburton Healthcare Investor Conference in Toronto on April 17 at 2:00 p.m. ET. #BloomBurton #BBHIC2024 ow.ly/fUpc50R72uP

We're looking forward to being part of another great @bloomburton conference! See you in Toronto. #BBHIC2024

That's a wrap for the Bloom Burton Healthcare Investor Conference 2024! Thank you to @bloomburton for hosting a fantastic conference and congratulations to all presenting companies. We were delighted to see many LSBC members among the speakers. #BBHIC2024

Thank you to Dr. Benoit-Antoine Bacon for highlighting Gandeeva Therapeutics and our CEO, Sriram Subramaniam Sriram Subramaniam at this week's presentation to the Greater Vancouver Board of Trade. We’re proud of our University of British Columbia roots!

Thrilled to be part of the CIEBH consortium, with partners Gandeeva Therapeutics and global pharma companies including GSK. Our project PROGENITER will leverage Canada’s investment in biomanufacturing and life sciences to bolster pandemic preparedness. ow.ly/MbL450S4FW2

Gandeeva Therapeutics is proud to partner with PROGENITER, a collaboration between University of British Columbia , Simon Fraser University, and global pharmaceutical and biotechnology companies in Canada to scale up Canadian pandemic preparedness.

It is with great sadness that we mourn the passing of Don Kania, our Board Chair and dear friend, on July 28, 2024. We will miss him terribly. Our thoughts are with his family and loved ones. ow.ly/BSpn50STiuh

Biotech has an important role to play in helping academic and government partners scale up their capacity for pandemic preparedness, and we're proud to partner with PROGENITER to accelerate pandemic readiness at home and around the world. ow.ly/43u750TbeCI

Thank you to BIV News for highlighting Gandeeva Therapeutics alongside Variational AI and AbCellera in their latest feature on AI-powered drug discovery. We’re working hard to leverage AI tools to engineer home-grown solutions to global health problems. ow.ly/sCHC50ToHnJ

Congrats to @HHMINews on the launch of Beautiful Biology! Beautiful Biology showcases images from scientists, photographers, and educators worldwide including our CEO, Sriram Subramaniam, from his research at the National Cancer Institute at the NIH.

We're aware that someone is misrepresenting an employee of Gandeeva Therapeutics in emails offering employment interviews. Please do not respond to these emails. We do not solicit interviews for jobs not posted to gandeeva.com/careers.

This year’s chemistry laureates Demis Hassabis and John Jumper have developed an AI model, AlphaFold2, to solve a 50-year-old problem: predicting proteins’ complex structures. Check out two examples of protein structures determined using AlphaFold2. First up, a bacterial enzyme

Congratulations to David Baker, Demis Hassabis, and John Jumper on their 2024 Nobel Prize in Chemistry, and to Geoffrey Hinton and JJ Hopfield on their 2024 Nobel Prize in Physics! Their contributions will have a transformative societal impact. ow.ly/yiGq50TIox5

When computational predictions, protein biochemistry, medicinal chemistry, and assays converge into a single validating cryo-EM image, it draws an enthusiastic crowd.

These Gandeeva ghouls are committed to excellence, whether in meetings or costume. We can’t imagine a more frightfully fun group of science thinkers and business doers. #lockedin #halloween

As 2024 draws to a close, we’re taking some time to rest and reflect on the many achievements that our teams have driven throughout the year. Our offices will be closed from noon on December 24, and will reopen at 8:00 a.m. on January 2. 2025. We wish you a joyful holiday season!

We're looking forward to being back in San Francisco for JPM2025. To schedule a meeting with our team, please reach out via DM.

Dr. Jason Crawford, EVP Drug Discovery, will speak at the 2025 Cell Signaling Breakthroughs Symposium in Vancouver, BC on February 19, 2025.